Stephen Mandel - Lone Pine Capital
Holding/activity history for Ascendis Pharma (ASND)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2021 Q4 | 0 | 0 | Sell 100.00% | 0.77 | |
| 2021 Q3 | 1,436,981 | 0.77 | $159.39 | ||
| 2021 Q2 | 1,436,981 | 0.61 | $131.55 | ||
| 2021 Q1 | 1,436,981 | 0.67 | Add 60.64% | 0.25 | $128.88 |
| 2020 Q4 | 894,533 | 0.54 | Buy | 0.54 | $166.78 |